IGC-1C

N/A

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameIGC-1C
Drug Alias NameIGC-1C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau modulatorsGlucagon-like peptide 1 receptor agonists
TargetsMicrotubule-associated protein tauGlucagon-like peptide 1 receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIGC Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesIGC Pharma Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A